These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9520369)

  • 41. Reversion of the transformed phenotypes of v-H-ras NIH3T3 cells by flavonoids through attenuating the content of phosphotyrosine.
    Kuo ML; Lin JK; Huang TS; Yang NC
    Cancer Lett; 1994 Nov; 87(1):91-7. PubMed ID: 7525047
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ornithine decarboxylase- and ras-induced cell transformations: reversal by protein tyrosine kinase inhibitors and role of pp130CAS.
    Auvinen M; Paasinen-Sohns A; Hirai H; Andersson LC; Hölttä E
    Mol Cell Biol; 1995 Dec; 15(12):6513-25. PubMed ID: 8524216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Histone deacetylase inhibitor blocks proliferation of cells transformed with oncogenes E1A and cHa-ras].
    Abramova MV; Svetlikova SB; Aksenov ND; Pospelova TV; Pospelov VA
    Tsitologiia; 2003; 45(11):1100-8. PubMed ID: 14989149
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis.
    Korfei M; Stelmaszek D; MacKenzie B; Skwarna S; Chillappagari S; Bach AC; Ruppert C; Saito S; Mahavadi P; Klepetko W; Fink L; Seeger W; Lasky JA; Pullamsetti SS; Krämer OH; Guenther A
    PLoS One; 2018; 13(11):e0207915. PubMed ID: 30481203
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.
    Richon VM; Emiliani S; Verdin E; Webb Y; Breslow R; Rifkind RA; Marks PA
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3003-7. PubMed ID: 9501205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin.
    Han JW; Ahn SH; Park SH; Wang SY; Bae GU; Seo DW; Kwon HK; Hong S; Lee HY; Lee YW; Lee HW
    Cancer Res; 2000 Nov; 60(21):6068-74. PubMed ID: 11085529
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo.
    Fournel M; Bonfils C; Hou Y; Yan PT; Trachy-Bourget MC; Kalita A; Liu J; Lu AH; Zhou NZ; Robert MF; Gillespie J; Wang JJ; Ste-Croix H; Rahil J; Lefebvre S; Moradei O; Delorme D; Macleod AR; Besterman JM; Li Z
    Mol Cancer Ther; 2008 Apr; 7(4):759-68. PubMed ID: 18413790
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Partial transformation of mouse fibroblastic and epithelial cell lines with the v-myc oncogene.
    Falcone G; Summerhayes IC; Paterson H; Marshall CJ; Hall A
    Exp Cell Res; 1987 Jan; 168(1):273-84. PubMed ID: 3023119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histone deacetylase inhibitors decrease cocaine but not sucrose self-administration in rats.
    Romieu P; Host L; Gobaille S; Sandner G; Aunis D; Zwiller J
    J Neurosci; 2008 Sep; 28(38):9342-8. PubMed ID: 18799668
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanism of cell cycle arrest caused by histone deacetylase inhibitors in human carcinoma cells.
    Kim YB; Ki SW; Yoshida M; Horinouchi S
    J Antibiot (Tokyo); 2000 Oct; 53(10):1191-200. PubMed ID: 11132966
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overlapping and Divergent Actions of Structurally Distinct Histone Deacetylase Inhibitors in Cardiac Fibroblasts.
    Schuetze KB; Stratton MS; Blakeslee WW; Wempe MF; Wagner FF; Holson EB; Kuo YM; Andrews AJ; Gilbert TM; Hooker JM; McKinsey TA
    J Pharmacol Exp Ther; 2017 Apr; 361(1):140-150. PubMed ID: 28174211
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapid induction of histone hyperacetylation and cellular differentiation in human breast tumor cell lines following degradation of histone deacetylase-1.
    Zhou Q; Melkoumian ZK; Lucktong A; Moniwa M; Davie JR; Strobl JS
    J Biol Chem; 2000 Nov; 275(45):35256-63. PubMed ID: 10938272
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preclinical anti-arthritic study and pharmacokinetic properties of a potent histone deacetylase inhibitor MPT0G009.
    Hsieh IN; Liou JP; Lee HY; Lai MJ; Li YH; Yang CR
    Cell Death Dis; 2014 Apr; 5(4):e1166. PubMed ID: 24722291
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suppression of invasion and MMP-9 expression in NIH 3T3 and v-H-Ras 3T3 fibroblasts by lovastatin through inhibition of ras isoprenylation.
    Wang IK; Lin-Shiau SY; Lin JK
    Oncology; 2000 Sep; 59(3):245-54. PubMed ID: 11053993
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence that sprouty 2 is necessary for sarcoma formation by H-Ras oncogene-transformed human fibroblasts.
    Lito P; Mets BD; Kleff S; O'Reilly S; Maher VM; McCormick JJ
    J Biol Chem; 2008 Jan; 283(4):2002-9. PubMed ID: 18048363
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B.
    Jeay S; Pianetti S; Kagan HM; Sonenshein GE
    Mol Cell Biol; 2003 Apr; 23(7):2251-63. PubMed ID: 12640111
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells.
    Hou M; Wang X; Popov N; Zhang A; Zhao X; Zhou R; Zetterberg A; Björkholm M; Henriksson M; Gruber A; Xu D
    Exp Cell Res; 2002 Mar; 274(1):25-34. PubMed ID: 11855854
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autoregulation of mouse histone deacetylase 1 expression.
    Schuettengruber B; Simboeck E; Khier H; Seiser C
    Mol Cell Biol; 2003 Oct; 23(19):6993-7004. PubMed ID: 12972616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced induction of c-fos but not of c-myc expressions in a nontumorigenic revertant R1 of Ej-ras-transformed NIH/3T3 cells treated with 12-O-tetradecanoylphorbol-13-acetate (TPA).
    Suzuki H; Fujita H; Ogiso Y; Oda A; Kuzumaki N; Uchino J
    Exp Cell Res; 1989 Oct; 184(2):524-8. PubMed ID: 2509225
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal.
    Young JC; Wu S; Hansteen G; Du C; Sambucetti L; Remiszewski S; O'Farrell AM; Hill B; Lavau C; Murray LJ
    Cytotherapy; 2004; 6(4):328-36. PubMed ID: 16146885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.